Joincare Pharmaceutical Group Industry Co.,Ltd.

600380.SS · Shanghai Stock Exchange · CNY

10,46CNY

−0,09 (−0,85 %)Stand 10. Nov., 7:00

Vortag 10,55

Kennzahlen

Eröffnung
10,50
Vortag
10,55
Tagesspanne
10,43 – 10,55
52 Wochen
9,00 – 12,85
Volumen
9,95 Mio.
Ø Volumen
18,43 Mio.
Börsenwert
19,14 Mrd. CNY
KGV
–
Gewinn je Aktie (TTM)
–
Dividendenrendite
–
Beta
0,1
Nächste Zahlen
–

Finanzen

Gerade nicht verfügbar.

Bewertung

Gerade nicht verfügbar.

Analysten

Einstufungen

Gerade nicht verfügbar.

Kursziel

Gerade nicht verfügbar.

Quartalszahlen

Gerade nicht verfügbar.

Dividenden und Splits

Gerade nicht verfügbar.

Aktiensplits

Gerade nicht verfügbar.

Eigentümer

Institutionen

Gerade nicht verfügbar.

Insider-Geschäfte

Gerade nicht verfügbar.

Vergleichbare Unternehmen

Gerade nicht verfügbar.

Über das Unternehmen

Joincare Pharmaceutical Group Industry Co., Ltd. is a Chinese enterprise primarily focused on the comprehensive process of researching, developing, producing, and commercializing pharmaceutical and healthcare products within China. The company boasts a broad pharmaceutical portfolio that includes both Western chemical drug preparations, addressing conditions such as respiratory, gastrointestinal, anti-infection, gonadotropic, and psychiatric disorders, as well as traditional Chinese medicines (TCM), with offerings for anti-tumor and cold relief. Beyond finished drugs, Joincare supplies chemical active pharmaceutical ingredients (APIs) and intermediates. Its operations also extend into the diagnostics sector, where it provides specialized reagents and equipment, such as an autoimmunity multiple detection platform and an IgM diagnostic kit. Furthermore, the company markets a range of health and wellness products, exemplified by American ginseng tea and Jingxin menocare essence. Joincare diversifies its business by engaging in the wholesale and retail of personal care items, including skincare products, cosmetics, and various other essential goods. Its products are available in diverse formats, such as hormone tablets, oral liquid formulations, and standard tablets. Established in 1992, Joincare Pharmaceutical Group maintains its principal offices in Shenzhen, China.

CEO
Nanqi Lin
Mitarbeitende
13.575
Hauptsitz
Shenzhen, GD, CN
Sektor
Healthcare
Branche
Drug Manufacturers - Specialty & Generic
Börsengang
8. Juni 2001

Nachrichten

Gerade nicht verfügbar.

Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.